SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-20-124908
Filing Date
2020-11-13
Accepted
2020-11-13 13:50:31
Documents
1
Effectiveness Date
2020-11-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5501
  Complete submission text file 0001104659-20-124908.txt   6568
Mailing Address 55 MADISON STREET SUITE 400 MORRISTOWN NJ 07960
Business Address 55 MADISON STREET SUITE 400 MORRISTOWN NJ 07960 940-391-3540
Alitair Pharmaceuticals, Inc. (Filer) CIK: 0001654448 (see all company filings)

IRS No.: 272999493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-380521 | Film No.: 201310610